)
)
Elicera Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Elicera Therapeutics
Access all reports
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The company focuses on developing next-generation cell and gene therapies aimed at treating cancer through immune-based approaches. Elicera's pipeline includes four main drug candidates, two of which are in the field of oncolytic viruses and two in CAR T-cell therapies. Their proprietary iTANK (ImmunoTherapies Activated with Nap for efficient Killing) platform is designed to enhance the efficacy of these therapies. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
ELIC
Country
🇸🇪 Sweden